Dipeptidyl peptidase-4 inhibitor anagliptin reduces fasting apolipoprotein B-48 levels in patients with type 2 diabetes: A randomized controlled trial-Reference-Cited by-同舟云学术

Dipeptidyl peptidase-4 inhibitor anagliptin reduces fasting apolipoprotein B-48 levels in patients with type 2 diabetes: A randomized controlled trial

Published:2020-01-28 Issue:1 Volume:15 Page:e0228004
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Onoue Takeshi^ORCID,Goto Motomitsu,Wada Eri,Furukawa Mariko,Okuji Takayuki,Okada Norio,Kobayashi Tomoko,Iwama Shintaro,Sugiyama Mariko,Tsunekawa Taku,Takagi Hiroshi,Hagiwara Daisuke,Ito Yoshihiro,Morishita Yoshiaki^ORCID,Seino Yusuke,Suga Hidetaka,Banno Ryoichi,Hamada Yoji,Ando Masahiko,Yamamori Etsuko,Arima Hiroshi

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference36 articles.

1. The insulin resistance syndrome: impact on lipoprotein metabolism and atherothrombosis;HN Ginsberg;J Cardiovasc Risk,2000

2. Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS: 23);RC Turner;BMJ,1998

3. Chronic inhibition of dipeptidyl peptidase-4 with a sitagliptin analog preserves pancreatic beta-cell mass and function in a rodent model of type 2 diabetes;J Mu;Diabetes,2006

4. Effects of chronic administration of alogliptin on the development of diabetes and β-cell function in high fat diet/streptozotocin diabetic mice;X Zhang;Diabetes Obes Metab,2011

5. Multifactorial intervention in Type 2 diabetes: the promise of incretin-based therapies;F Giorgino;J Endocrinol Invest,2011

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of dipeptidyl peptidase-4 inhibitors on tumor necrosis factor alpha levels in patients with type 2 diabetes mellitus;European Journal of Medical Research;2024-07-12

2. Role of anagliptin, a dipeptidyl peptidase-4 inhibitor, in managing type 2 diabetes: A systematic review and meta-analysis;Medicine;2024-07-12

3. Loss of mitogen‐activated protein kinase phosphate‐5 aggravates islet dysfunction in mice with type 1 and type 2 diabetes;The FASEB Journal;2024-02-02

4. Anagliptin prevents lipopolysaccharide (LPS)- induced inflammation and activation of macrophages;International Immunopharmacology;2022-03

5. Combination Therapy With Ustekinumab Plus Intensive Granulocyte and Monocyte Adsorptive Apheresis in Patients With Refractory Ulcerative Colitis;Journal of Clinical Medicine Research;2021-11